Cargando…
Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells
BACKGROUND: The prognosis for patients with disseminated lung cancer is poor and current treatments have limited survival benefit as resistance often occurs, and is often associated with significant toxicity. A possible strategy to improve treatment and evade chemoresistance may be to find new combi...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5667477/ https://www.ncbi.nlm.nih.gov/pubmed/29096687 http://dx.doi.org/10.1186/s13104-017-2842-z |